Inferred inactivation of the Cftr gene in the duodena of mice exposed to hexavalent chromium (Cr(VI)) in drinking water supports its tumor-suppressor status and implies its potential role in Cr(VI)-induced carcinogenesis of the small intestines.


Journal

Toxicology and applied pharmacology
ISSN: 1096-0333
Titre abrégé: Toxicol Appl Pharmacol
Pays: United States
ID NLM: 0416575

Informations de publication

Date de publication:
15 12 2021
Historique:
received: 15 06 2021
revised: 12 10 2021
accepted: 19 10 2021
pubmed: 25 10 2021
medline: 30 12 2021
entrez: 24 10 2021
Statut: ppublish

Résumé

Carcinogenicity of hexavalent chromium [Cr (VI)] has been supported by a number of epidemiological and animal studies; however, its carcinogenic mode of action is still incompletely understood. To identify mechanisms involved in cancer development, we analyzed gene expression data from duodena of mice exposed to Cr(VI) in drinking water. This analysis included (i) identification of upstream regulatory molecules that are likely responsible for the observed gene expression changes, (ii) identification of annotated gene expression data from public repositories that correlate with gene expression changes in duodena of Cr(VI)-exposed mice, and (iii) identification of hallmark and oncogenic signature gene sets relevant to these data. We identified the inactivated CFTR gene among the top scoring upstream regulators, and found positive correlations between the expression data from duodena of Cr(VI)-exposed mice and other datasets in public repositories associated with the inactivation of the CFTR gene. In addition, we found enrichment of signatures for oncogenic signaling, sustained cell proliferation, impaired apoptosis and tissue remodeling. Results of our computational study support the tumor-suppressor role of the CFTR gene. Furthermore, our results support human relevance of the Cr(VI)-mediated carcinogenesis observed in the small intestines of exposed mice and suggest possible groups that may be more vulnerable to the adverse outcomes associated with the inactivation of CFTR by hexavalent chromium or other agents. Lastly, our findings predict, for the first time, the role of CFTR inactivation in chemical carcinogenesis and expand the range of plausible mechanisms that may be operative in Cr(VI)-mediated carcinogenesis of intestinal and possibly other tissues.

Identifiants

pubmed: 34688701
pii: S0041-008X(21)00377-X
doi: 10.1016/j.taap.2021.115773
pmc: PMC9659473
mid: NIHMS1837088
pii:
doi:

Substances chimiques

Cftr protein, mouse 0
Drinking Water 0
Tumor Suppressor Proteins 0
Water Pollutants, Chemical 0
Chromium 0R0008Q3JB
Cystic Fibrosis Transmembrane Conductance Regulator 126880-72-6
chromium hexavalent ion 18540-29-9

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

115773

Subventions

Organisme : Intramural EPA
ID : EPA999999
Pays : United States

Informations de copyright

Published by Elsevier Inc.

Références

World J Gastrointest Oncol. 2016 Mar 15;8(3):282-8
pubmed: 26989463
Med Sci Monit. 2017 Feb 22;23:966-974
pubmed: 28225751
J Appl Toxicol. 2020 Jan;40(1):169-175
pubmed: 31466122
Science. 2009 Mar 27;323(5922):1747-50
pubmed: 19251594
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947
pubmed: 30371878
Environ Health Perspect. 2009 Sep;117(9):1441-7
pubmed: 19750111
Int J Cancer. 2009 Dec 15;125(12):2953-6
pubmed: 19551859
Biochim Biophys Acta. 2014 Mar;1843(3):618-28
pubmed: 24373847
Cell Physiol Biochem. 2006;17(5-6):269-78
pubmed: 16791002
Cell Mol Gastroenterol Hepatol. 2017 Dec 07;5(3):253-271
pubmed: 29675451
J Natl Cancer Inst. 2013 Jan 16;105(2):122-9
pubmed: 23178438
J Biol Chem. 2012 May 18;287(21):17130-17139
pubmed: 22467879
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Int J Environ Res Public Health. 2013 Dec 20;11(1):202-17
pubmed: 24452255
Eur J Pharmacol. 2019 Oct 15;861:172598
pubmed: 31408647
J R Soc Med. 1996;89 Suppl 27:38-43
pubmed: 8778449
Metallomics. 2009;1(3):222-8
pubmed: 20461219
Nat Genet. 2011 Nov 06;43(12):1202-9
pubmed: 22057237
Toxicol Sci. 2017 Jul 1;158(1):199-212
pubmed: 28472532
FASEB J. 2012 Feb;26(2):533-45
pubmed: 21990373
Thorax. 2010 Jun;65(6):528-33
pubmed: 20522851
Int J Oncol. 2015 May;46(5):2107-15
pubmed: 25760446
Sci China Life Sci. 2012 Sep;55(9):753-60
pubmed: 23015123
Cell Death Dis. 2018 Feb 15;9(3):265
pubmed: 29449559
J Environ Pathol Toxicol Oncol. 2008;27(2):77-88
pubmed: 18540844
Cell Mol Life Sci. 2018 May;75(10):1737-1756
pubmed: 29411041
PLoS One. 2010 Nov 15;5(11):e13984
pubmed: 21085593
Oncogene. 2016 Aug 11;35(32):4179-87
pubmed: 26751771
Cancer. 2010 Jan 1;116(1):203-9
pubmed: 19885835
Oncogene. 2013 May 2;32(18):2282-91, 2291.e1-7
pubmed: 22797075
Respiration. 2000;67(2):117-33
pubmed: 10773783
Channels (Austin). 2018;12(1):284-290
pubmed: 30152709
Bioinformatics. 2014 Feb 15;30(4):523-30
pubmed: 24336805
Chest. 2013 Aug;144(2):498-506
pubmed: 23538783
Am J Physiol Cell Physiol. 2006 Jan;290(1):C262-70
pubmed: 16162662
N Engl J Med. 1995 Feb 23;332(8):494-9
pubmed: 7830730
Cancer Prev Res (Phila). 2018 Jan;11(1):4-15
pubmed: 29109117
Arch Environ Health. 1994 Jul-Aug;49(4):297-302
pubmed: 8031188
Toxicol Pathol. 2013 Feb;41(2):326-42
pubmed: 23334696
Nat Genet. 2015 Feb;47(2):142-50
pubmed: 25559195
PLoS One. 2010 Sep 29;5(9):
pubmed: 20927376
Curr Cancer Drug Targets. 2009 Feb;9(1):32-71
pubmed: 19200050
Eur Respir Rev. 2018 Mar 28;27(147):
pubmed: 29592863
Am J Physiol Gastrointest Liver Physiol. 2007 Jul;293(1):G222-9
pubmed: 17615178
Cell Death Dis. 2013 Oct 03;4:e817
pubmed: 24091660
Physiol Rev. 1999 Jan;79(1 Suppl):S215-55
pubmed: 9922383
FASEB J. 2009 Jan;23(1):204-13
pubmed: 18779379
IARC Monogr Eval Carcinog Risks Hum. 1993;58:119-237
pubmed: 8022055
Toxicol Sci. 2011 Sep;123(1):58-70
pubmed: 21712504
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Toxicol Appl Pharmacol. 2012 Jul 15;262(2):124-38
pubmed: 22561333
Ann Hum Genet. 2003 Sep;67(Pt 5):471-85
pubmed: 12940920
Environ Health Perspect. 2009 May;117(5):716-22
pubmed: 19479012
Toxicol Appl Pharmacol. 2012 Feb 15;259(1):13-26
pubmed: 22155349
Gut. 2012 Sep;61(9):1291-8
pubmed: 21997556
PLoS One. 2012;7(11):e50837
pubmed: 23226399
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Am J Respir Crit Care Med. 2006 May 15;173(10):1139-44
pubmed: 16497995
Am J Epidemiol. 2011 Feb 15;173(4):414-20
pubmed: 21190988
Biochim Biophys Acta. 2013 Dec;1833(12):2961-2969
pubmed: 23916755
Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6565-9
pubmed: 1713683
Toxicol Sci. 2010 Jul;116(1):349-58
pubmed: 20363832
Am J Physiol Gastrointest Liver Physiol. 2004 Jun;286(6):G1032-41
pubmed: 14739145
Am J Physiol Cell Physiol. 2006 Mar;290(3):C793-801
pubmed: 16236827
Hum Mol Genet. 2007 Apr 15;16 Spec No 1:R14-20
pubmed: 17613544
J Allergy Clin Immunol. 2019 Oct;144(4):1004-1010.e4
pubmed: 31279013
IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt C):11-465
pubmed: 23189751
PLoS One. 2012;7(12):e47405
pubmed: 23272037
Cell Mol Life Sci. 2017 Jan;74(1):93-115
pubmed: 27714410
Cell Stem Cell. 2018 Feb 1;22(2):206-220.e4
pubmed: 29395055
Cancer Manag Res. 2020 Jun 08;12:4261-4270
pubmed: 32606923
J Physiol. 1997 Sep 1;503 ( Pt 2):333-46
pubmed: 9306276
J Natl Cancer Inst. 1999 Jul 21;91(14):1194-210
pubmed: 10413421
J Biol Chem. 2002 Aug 2;277(31):27912-8
pubmed: 12023951
Respir Res. 2014 Jun 23;15:69
pubmed: 24957904
Environ Health Perspect. 2009 Jul;117(7):1108-15
pubmed: 19654921
Life Sci. 2016 Apr 15;151:339-347
pubmed: 26916823
Toxicol Sci. 2021 Feb 26;180(1):38-50
pubmed: 33404626
Am J Physiol Cell Physiol. 2007 Feb;292(2):C756-66
pubmed: 16987996
Am J Physiol Lung Cell Mol Physiol. 2005 Jan;288(1):L77-83
pubmed: 15361357
Int J Mol Sci. 2020 Apr 21;21(8):
pubmed: 32326161
Front Oncol. 2019 Feb 04;9:24
pubmed: 30778374
Gut. 2007 Aug;56(8):1153-63
pubmed: 17446304
Int J Mol Sci. 2020 Jul 06;21(13):
pubmed: 32640524
Am J Physiol Lung Cell Mol Physiol. 2005 May;288(5):L894-902
pubmed: 15626749

Auteurs

Roman Mezencev (R)

Center for Public Health and Environmental Assessment, Office of Research and Development, US EPA, Washington, DC, United States. Electronic address: Mezencev.Roman@epa.gov.

Scott S Auerbach (SS)

National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Classifications MeSH